Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Feasibility Study of Metformin/Ritonavir Combination Treatment in Patients With Relapsed/Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia

NCT02948283 is registered in ClinicalTrials.gov with City of Hope Medical Center as lead sponsor.

NCT NCT02948283
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02948283 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Feasibility Study of Metformin/Ritonavir Combination Treatment in Patients With Relapsed/Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia
Lead sponsor
City of Hope Medical Center
Phase
Phase 1
Overall status
Completed
Start date
September 5, 2017
Completion date
December 1, 2017
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, fatigue, fever, lymphadenopathy, lymphocytosis, night sweats, recurrent chronic lymphocytic leukemia, recurrent plasma cell myeloma, refractory chronic lymphocytic leukemia, refractory plasma cell myeloma, splenomegaly, thrombocytopenia, weight loss